A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of single and multiple doses of
domperidone on the QTc interval duration in healthy adult volunteers at domperidone doses of
10 mg four times a day (q.i.d.) and 20 mg q.i.d.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Research & Development, LLC
Treatments:
Domperidone Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination